Application 021210
- Type
- NDA
- Sponsor
- STEVENS J
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 002 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 003 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 004 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 005 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 006 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 007 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 008 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 009 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 010 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 011 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | Yes |
| 012 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021210-001 | UNITHROID | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-002 | UNITHROID | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-003 | UNITHROID | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-004 | UNITHROID | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-005 | UNITHROID | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-006 | UNITHROID | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-007 | UNITHROID | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-008 | UNITHROID | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-009 | UNITHROID | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-010 | UNITHROID | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-011 | UNITHROID | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 |
| N021210-012 | UNITHROID | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021210-001 | AB1 |
| N021210-001 | AB2 |
| N021210-001 | AB3 |
| N021210-002 | AB1 |
| N021210-002 | AB2 |
| N021210-002 | AB3 |
| N021210-003 | AB1 |
| N021210-003 | AB2 |
| N021210-003 | AB3 |
| N021210-004 | AB1 |
| N021210-004 | AB2 |
| N021210-004 | AB3 |
| N021210-005 | AB1 |
| N021210-005 | AB2 |
| N021210-005 | AB3 |
| N021210-006 | AB1 |
| N021210-006 | AB2 |
| N021210-006 | AB3 |
| N021210-007 | AB1 |
| N021210-007 | AB2 |
| N021210-007 | AB3 |
| N021210-008 | AB1 |
| N021210-008 | AB2 |
| N021210-008 | AB3 |
| N021210-009 | AB1 |
| N021210-009 | AB2 |
| N021210-009 | AB3 |
| N021210-010 | AB1 |
| N021210-010 | AB2 |
| N021210-010 | AB3 |
| N021210-011 | AB1 |
| N021210-011 | AB2 |
| N021210-011 | AB3 |
| N021210-012 | AB1 |
| N021210-012 | AB2 |
| N021210-012 | AB3 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-005 | UNITHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-006 | UNITHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-007 | UNITHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-008 | UNITHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-009 | UNITHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-010 | UNITHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-011 | UNITHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-012 | UNITHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-005 | UNITHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-006 | UNITHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-007 | UNITHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-008 | UNITHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-009 | UNITHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-010 | UNITHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-011 | UNITHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-012 | UNITHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-005 | UNITHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-006 | UNITHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-007 | UNITHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-008 | UNITHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-009 | UNITHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-010 | UNITHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-011 | UNITHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-012 | UNITHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021210-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-001 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-001 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-002 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-002 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-003 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-003 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-003 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-004 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-004 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-004 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-005 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-005 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-005 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-006 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-006 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-006 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-007 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-007 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-007 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-008 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-008 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-008 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-009 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-009 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-009 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-010 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-010 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-010 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-011 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-011 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-011 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-012 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-012 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-012 | AB3 | 3 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-001 | AB2 | 2 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-001 | AB3 | 3 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-002 | AB1 | 1 | caaa826d4ba7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | abe173cc-1579-43a5-b12d-a31958d0a539 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | c968836a-f94c-4d13-e053-2995a90a8df5 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Amneal Pharmaceuticals NY LLC | fca88c97-5cd4-4834-ba87-deb5bd637788 | 2024-12-06 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 69238-1830 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 2f0657d5-3e5c-4249-bfaa-7f5ef1528672 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 97e28b00-9913-463f-9de2-08c828edbe67 | 2020-03-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 05ab038e-45fa-488e-a05e-12a2dd3564c1 | 2020-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | b81720f9-2836-4c1d-8691-0f6acef13316 | 2020-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 434075d5-a82b-4f17-85e6-4c1922663dbc | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 18c7c63a-642e-47fe-a8ee-12aaf652b2aa | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Unithroid | LEVOTHYROXINE SODIUM | Amneal Pharmaceuticals LLC | 07562e72-7eaa-4ce6-94f0-e08814787e50 | 2019-06-19 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 60846-812 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 60846-812 | Unithroid | levothyroxine sodium | Amneal Pharmaceuticals LLC | NDA | Current |
| 60846-812 | Unithroid | levothyroxine sodium | Gemini Laboratories, LLC | NDA | Current |
| 61919-403 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | DirectRX | NDA AUTHORIZED GENERIC | Current |
| 61919-783 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | DirectRX | NDA | Current |
| 61919-976 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | DirectRX | NDA AUTHORIZED GENERIC | Current |
| 63187-459 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-459 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-460 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-460 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-496 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-496 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-549 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-549 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-569 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-569 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-572 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-572 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-573 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-573 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-581 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-581 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-611 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-611 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-635 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63187-635 | Levothyroxine Sodium | Levothyroxine Sodium | Proficient Rx LP | NDA | Current |
| 63629-1838 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-1838 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-1839 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-2697 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-2697 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-2712 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-2712 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-2718 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-2718 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-2727 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-2806 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-2806 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-4244 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-4245 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-4245 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-4251 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-6646 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 63629-7132 | Levothyroxine Sodium | Levothyroxine Sodium | Bryant Ranch Prepack | NDA | Current |
| 64725-1342 | Levothyroxine Sodium | Levothyroxine Sodium | TYA Pharmaceuticals | NDA | Current |
| 66336-337 | Levothyroxine Sodium | Levothyroxine Sodium | Dispensing Solutions, Inc. | NDA | Current |
| 66336-357 | Levothyroxine Sodium | Levothyroxine Sodium | Dispensing Solutions, Inc. | NDA | Current |
| 66336-427 | Levothyroxine Sodium | Levothyroxine Sodium | Dispensing Solutions, Inc. | NDA | Current |
| 66336-571 | Levothyroxine Sodium | Levothyroxine Sodium | Dispensing Solutions, Inc. | NDA | Current |
| 67296-1680 | Levothyroxine Sodium | Levothyroxine Sodium | RedPharm Drug, Inc. | NDA | Current |
| 67296-1680 | Levothyroxine Sodium | Levothyroxine Sodium | RedPharm Drug, Inc. | NDA | Current |
| 68071-4709 | Levothyroxine Sodium | Levothyroxine Sodium | NuCare Pharmaceuticals,Inc. | NDA | Current |
| 68071-4709 | Levothyroxine Sodium | Levothyroxine Sodium | NuCare Pharmaceuticals,Inc. | NDA | Current |
| 68071-4714 | Levothyroxine Sodium | Levothyroxine Sodium | NuCare Pharmaceuticals,Inc. | NDA | Current |
| 68071-4731 | Levothyroxine Sodium | Levothyroxine Sodium | NuCare Pharmaceuticals,Inc. | NDA | Current |
| 68071-4731 | Levothyroxine Sodium | Levothyroxine Sodium | NuCare Pharmaceuticals,Inc. | NDA | Current |
| 68071-4735 | Levothyroxine Sodium | Levothyroxine Sodium | NuCare Pharmaceuticals,Inc. | NDA | Current |
| 68071-4735 | Levothyroxine Sodium | Levothyroxine Sodium | NuCare Pharmaceuticals,Inc. | NDA | Current |
| 68071-4767 | Levothyroxine Sodium | Levothyroxine Sodium | NuCare Pharmaceuticals,Inc. | NDA | Current |
| 68071-4767 | Levothyroxine Sodium | Levothyroxine Sodium | NuCare Pharmaceuticals,Inc. | NDA | Current |
| 68788-7325 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals Inc. | NDA | Current |
| 68788-7348 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals Inc. | NDA | Current |
| 68788-7348 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals Inc. | NDA | Current |
| 68788-7348 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals Inc. | NDA | Current |
| 68788-7352 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals Inc. | NDA | Current |
| 68788-7352 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals Inc. | NDA | Current |
| 68788-9156 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 68788-9157 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 68788-9159 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 68788-9160 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 68788-9161 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 68788-9162 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 68788-9163 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 68788-9164 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 68788-9165 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 68788-9168 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 68788-9437 | Levothyroxine Sodium | Levothyroxine Sodium | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 69238-1830 | Levothyroxine Sodium | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | NDA | Current |
| 69238-1830 | Levothyroxine Sodium | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | NDA | Current |
| 69238-1830 | Levothyroxine Sodium | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | NDA | Current |
| 69238-1830 | Levothyroxine Sodium | Levothyroxine Sodium | Amneal Pharmaceuticals LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 56834 | SUPPL | 2018-12-20 |
| 56720 | SUPPL | 2018-12-12 |
| 21510 | SUPPL | 2011-02-15 |
| 44106 | ORIG | 2009-05-30 |
| 36360 | SUPPL | 2008-02-14 |
| 27077 | SUPPL | 2008-02-14 |
| 21509 | SUPPL | 2005-05-13 |
| 21508 | SUPPL | 2005-05-13 |
| 4644 | SUPPL | 2004-12-22 |
| 27076 | SUPPL | 2004-06-24 |
| 42031 | ORIG | 2000-08-21 |
| 27075 | ORIG | 2000-08-21 |
| 14639 | ORIG | 2000-08-21 |